These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9466318)

  • 1. Pathogenesis of Graves' disease: molecular analysis of anti-thyrotropin receptor antibodies.
    Akamizu T; Mori T; Nakao K
    Endocr J; 1997 Oct; 44(5):633-46. PubMed ID: 9466318
    [No Abstract]   [Full Text] [Related]  

  • 2. Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves' disease.
    Hargreaves CE; Grasso M; Hampe CS; Stenkova A; Atkinson S; Joshua GW; Wren BW; Buckle AM; Dunn-Walters D; Banga JP
    J Immunol; 2013 Jun; 190(11):5373-81. PubMed ID: 23630351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin heavy chain variable region genes contribute to the induction of thyroid-stimulating antibodies in recombinant inbred mice.
    Rapoport B; Williams RW; Chen CR; McLachlan SM
    Genes Immun; 2010 Apr; 11(3):254-63. PubMed ID: 20407472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
    Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
    Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
    [No Abstract]   [Full Text] [Related]  

  • 5. Insight into Graves' hyperthyroidism from animal models.
    McLachlan SM; Nagayama Y; Rapoport B
    Endocr Rev; 2005 Oct; 26(6):800-32. PubMed ID: 15827111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs.
    Akamizu T; Matsuda F; Okuda J; Li H; Kanda H; Watanabe T; Honjo T; Mori T
    J Immunol; 1996 Oct; 157(7):3148-52. PubMed ID: 8816426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal relationships between thyroid-stimulating hormone receptor-stimulating antibodies illustrate the effect of hypermutation on antibody function.
    Padoa CJ; Larsen SL; Hampe CS; Gilbert JA; Dagdan E; Hegedus L; Dunn-Walters D; Banga JP
    Immunology; 2010 Feb; 129(2):300-8. PubMed ID: 19845794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
    Ochi Y; Kajita Y; Hamazu M; Nagata A
    Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
    Rapoport B; Aliesky HA; Chen CR; McLachlan SM
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of a TSH receptor monoclonal antibody: insight into Graves' disease pathogenesis.
    Chen CR; Hubbard PA; Salazar LM; McLachlan SM; Murali R; Rapoport B
    Mol Endocrinol; 2015 Jan; 29(1):99-107. PubMed ID: 25419797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.
    Kim WB; Chung HK; Park YJ; Park DJ; Tahara K; Kohn LD; Cho BY
    Thyroid; 2000 Jul; 10(7):579-86. PubMed ID: 10958310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The latest progress in the pathogenesis and diagnosis of Graves' disease].
    Kimura T; Okamoto Y
    Nihon Rinsho; 2012 Nov; 70(11):1908-12. PubMed ID: 23214060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.
    Hirooka Y; Li C; Takagi J; Gotoh M; Habu S; Yasaka-Nomura T; Ishihara R; Nakasone Y; Nakamura R; Morikawa R; Otake K; Nogimori T; Ishizuki Y
    Int J Clin Pharmacol Res; 2004; 24(4):111-6. PubMed ID: 15754915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients.
    Tahara K; Ban T; Minegishi T; Kohn LD
    Biochem Biophys Res Commun; 1991 Aug; 179(1):70-7. PubMed ID: 1883391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different genotypes of a functional polymorphism of the TSHR gene are associated with the development and severity of Graves' and Hashimoto's diseases.
    Inoue N; Watanabe M; Katsumata Y; Hidaka Y; Iwatani Y
    Tissue Antigens; 2013 Oct; 82(4):288-90. PubMed ID: 23962080
    [No Abstract]   [Full Text] [Related]  

  • 18. Limitations of the semisynthetic library approach for obtaining human monoclonal autoantibodies to the thyrotropin receptor of Graves' disease.
    Van Der Heijden JH; De Bruin TW; Glaudemans KA; De Kruif J; Banga JP; Logtenberg T
    Clin Exp Immunol; 1999 Nov; 118(2):205-12. PubMed ID: 10540180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of assays for TSH-receptor antibodies.
    Bitcon V; Donnelly J; Kiaei D
    J Endocrinol Invest; 2016 Oct; 39(10):1195-6. PubMed ID: 27531172
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways.
    Gilbert JA; Gianoukakis AG; Salehi S; Moorhead J; Rao PV; Khan MZ; McGregor AM; Smith TJ; Banga JP
    J Immunol; 2006 Apr; 176(8):5084-92. PubMed ID: 16585606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.